BioVAT-HF-DZHK20: Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Device in Terminal Heart Failure
| Institution | Georg-August-Universität Göttingen - Universitätsmedizin |
|---|---|
| Project leader | Wolfram-Hubertus Zimmermann |
| Site | Göttingen |
| Project type | Klinische Studie |
| Funding | € 1.176.657,23 |
| Begin | 01.07.2019 |
| End | 06.01.2028 |
| Partnerprojekte |
Förderkennzeichen
81X1300119
Projektnummer
1110